These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30455355)

  • 1. Physiological and pathophysiological characteristics of ataxin-3 isoforms.
    Weishäupl D; Schneider J; Peixoto Pinheiro B; Ruess C; Dold SM; von Zweydorf F; Gloeckner CJ; Schmidt J; Riess O; Schmidt T
    J Biol Chem; 2019 Jan; 294(2):644-661. PubMed ID: 30455355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.
    Potapenko A; Davidson JM; Lee A; Laird AS
    Biochem J; 2024 Mar; 481(6):461-480. PubMed ID: 38497605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease.
    Raposo M; Hübener-Schmid J; Tagett R; Ferreira AF; Vieira Melo AR; Vasconcelos J; Pires P; Kay T; Garcia-Moreno H; Giunti P; Santana MM; Pereira de Almeida L; Infante J; van de Warrenburg BP; de Vries JJ; Faber J; Klockgether T; Casadei N; Admard J; Schöls L; Riess O; ; Costa MDC; Lima M
    Neurobiol Dis; 2024 Apr; 193():106456. PubMed ID: 38423193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machado-Joseph Disease: A Stress Combating Deubiquitylating Enzyme Changing Sides.
    Dantuma NP; Herzog LK
    Adv Exp Med Biol; 2020; 1233():237-260. PubMed ID: 32274760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry analyses of normal and polyglutamine expanded ataxin-3 reveal novel interaction partners involved in mitochondrial function.
    Kristensen LV; Oppermann FS; Rauen MJ; Fog K; Schmidt T; Schmidt J; Harmuth T; Hartmann-Petersen R; Thirstrup K
    Neurochem Int; 2018 Jan; 112():5-17. PubMed ID: 29111377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3).
    Bettencourt C; Santos C; Montiel R; Costa Mdo C; Cruz-Morales P; Santos LR; Simões N; Kay T; Vasconcelos J; Maciel P; Lima M
    Neurogenetics; 2010 May; 11(2):193-202. PubMed ID: 19714377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
    Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
    Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation.
    Johnson SL; Ranxhi B; Libohova K; Tsou WL; Todi SV
    Elife; 2020 Sep; 9():. PubMed ID: 32955441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3.
    Johnson SL; Blount JR; Libohova K; Ranxhi B; Paulson HL; Tsou WL; Todi SV
    Neurobiol Dis; 2019 Dec; 132():104535. PubMed ID: 31310802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcript diversity of Machado-Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions.
    Bettencourt C; Raposo M; Ros R; Montiel R; Bruges-Armas J; Lima M
    J Mol Neurosci; 2013 Mar; 49(3):539-43. PubMed ID: 22706685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological interplay between
    Pereira Sena P; Weber JJ; Watchon M; Robinson KJ; Wassouf Z; Hauser S; Helm J; Abeditashi M; Schmidt J; Hübener-Schmid J; Schöls L; Laird AS; Riess O; Schmidt T
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34785590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyglutamine-Independent Features in Ataxin-3 Aggregation and Pathogenesis of Machado-Joseph Disease.
    Carvalho AL; Silva A; Macedo-Ribeiro S
    Adv Exp Med Biol; 2018; 1049():275-288. PubMed ID: 29427109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.
    Raj K; Akundi RS
    Mol Neurobiol; 2021 Jul; 58(7):3095-3118. PubMed ID: 33629274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP.
    Abeditashi M; Weber JJ; Pereira Sena P; Velic A; Kalimeri M; Incebacak Eltemur RD; Schmidt J; Hübener-Schmid J; Hauser S; Macek B; Riess O; Schmidt T
    Cell Mol Life Sci; 2022 Jul; 79(8):401. PubMed ID: 35794401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The parkin V380L variant is a genetic modifier of Machado-Joseph disease with impact on mitophagy.
    Weber JJ; Czisch L; Pereira Sena P; Fath F; Huridou C; Schwarz N; Incebacak Eltemur RD; Würth A; Weishäupl D; Döcker M; Blumenstock G; Martins S; Sequeiros J; Rouleau GA; Jardim LB; Saraiva-Pereira ML; França MC; Gordon CR; Zaltzman R; Cornejo-Olivas MR; van de Warrenburg BPC; Durr A; Brice A; Bauer P; Klockgether T; Schöls L; Riess O; ; Schmidt T
    Acta Neuropathol; 2024 Aug; 148(1):14. PubMed ID: 39088078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
    Li X; Liu H; Fischhaber PL; Tang TS
    Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.
    Goti D; Katzen SM; Mez J; Kurtis N; Kiluk J; Ben-Haïem L; Jenkins NA; Copeland NG; Kakizuka A; Sharp AH; Ross CA; Mouton PR; Colomer V
    J Neurosci; 2004 Nov; 24(45):10266-79. PubMed ID: 15537899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.
    Sutton JR; Blount JR; Libohova K; Tsou WL; Joshi GS; Paulson HL; Costa MDC; Scaglione KM; Todi SV
    Hum Mol Genet; 2017 Apr; 26(8):1419-1431. PubMed ID: 28158474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulnerability of frontal brain neurons for the toxicity of expanded ataxin-3.
    Schmidt J; Mayer AK; Bakula D; Freude J; Weber JJ; Weiss A; Riess O; Schmidt T
    Hum Mol Genet; 2019 May; 28(9):1463-1473. PubMed ID: 30576445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.